EGIP: An Evidence-Grounded Interaction Protocol for Clinical Agents
Organizations: Waseda University, Tokorozawa, Japan · Shanghai Jiao Tong University, Shanghai, China
Abstract
Interactive clinical agents acquire evidence through patient dialogue and diagnostic examinations, yet their performance also depends on how the interaction environment exposes information, available actions, and examination results. When these conditions are implicit or inconsistently controlled, final-answer accuracy can conflate diagnostic reasoning with the effects of the interaction protocol. We propose the Evidence-Grounded Interaction Protocol (EGIP), which enforces role-specific information boundaries, exposes diagnostic actions without revealing their results, retrieves examination results from stored clinical records, and organizes acquired evidence for final decision-making. By separating evidence acquisition from terminal prediction, EGIP enables different decision strategies to operate on the same observations. We evaluate EGIP across two clinical-agent frameworks, five datasets, and six language models. EGIP improves diagnostic accuracy over native baselines across all primary comparisons. A clinician review further shows that the proportion of automatically scored correct responses jointly judged evidence-supported rises from 10.20% to 36.55%. These findings support the effectiveness of EGIP as a unified interaction protocol for improving clinical-agent performance through controlled evidence access and acquisition.
Figures & tables
| Backbone | Method | MedQA | MedQA_Ext | NEJM | NEJM_Ext | MIMIC-IV |
|---|---|---|---|---|---|---|
| Qwen2.5-VL-7B | MedAgentSim | |||||
| + EGIP-Direct | ||||||
| AgentClinic | ||||||
| + EGIP-Direct | ||||||
| Llama3.1-8B | MedAgentSim | |||||
| + EGIP-Direct |
| Method | MedQA | MIMIC-IV |
|---|---|---|
| Llama3.3-70B-AWQ | ||
| MedAgentSim | ||
| + EGIP-Direct | ||
| AgentClinic | ||
| + EGIP-Direct | ||
| Qwen2.5-72B-AWQ | ||
| Dataset | Variant | Acc. (%) | Drop (pp) | Paired 95% CI |
| Panel A. Acquisition components | ||||
| MedQA | EGIP-Direct | – | – | |
| w/o action menu | 33.64 | [24.30, 42.68] | ||
| Native measurement access | 3.12 | [ , 8.10] | ||
| NEJM_Ext | EGIP-Direct | – | – | |
| w/o action menu | 4.44 | [ , 10.83] | ||
| Support rule / dataset | Native, (%) | Direct, (%) | (pp) | Paired 95% CI |
| Panel A. Correct-and-supported yield (539 complete pairs) | ||||
| Both clinicians (CSY) | 55/539 ( 10.20 ) | 197/539 ( 36.55 ) | +26.35 | [20.93, 31.79] |
| Clinician 1 | 112/539 (20.78) | 259/539 (48.05) | +27.27 | [21.59, 33.09] |
| Clinician 2 | 74/539 (13.73) | 233/539 (43.23) | +29.50 | [23.89, 35.12] |
| At least one clinician | 131/539 (24.30) | 295/539 (54.73) | +30.43 | [24.72, 36.19] |
| Panel B. Evidence support within the shared correct-answer subset (105 pairs) | ||||
Appendix figures & tables4 assets
Supplementary material from the paper’s appendix.
Appendix
| Model | Framework | Dataset | Paired 95% CI | Effect bounds | Conservative envelope | |
|---|---|---|---|---|---|---|
| Qwen | MAS | MedQA | 28.04 | [20.56, 35.83] | [1.25, 27.10] | [-6.54, 34.89] |
| Qwen | MAS | MedQA_Ext | 23.83 | [18.22, 29.60] | [0.62, 24.14] | [-5.14, 29.60] |
| Qwen | MAS | MIMIC-IV | 30.21 | [26.16, 34.26] | [9.26, 26.97] | [4.98, 30.90] |
| Qwen | MAS | NEJM | 53.33 | [20.00, 80.00] | [15.56, 55.56] | [-13.33, 82.22] |
| Qwen | MAS | NEJM_Ext | 34.17 | [26.39, 42.22] | [14.72, 40.56] | [6.94, 48.33] |
| Qwen | AC | MedQA | 23.68 | [15.26, 32.09] | [15.26, 28.04] | [6.85, 36.14] |
| Model | Framework | Dataset | Paired 95% CI | Effect bounds | Conservative envelope | |
|---|---|---|---|---|---|---|
| Qwen | MAS | MedQA | 3.12 | [-2.81, 9.35] | [-3.12, 8.41] | [-9.97, 14.33] |
| Qwen | MAS | MedQA_Ext | 3.89 | [-0.31, 7.79] | [-1.56, 8.10] | [-5.76, 12.15] |
| Qwen | MAS | MIMIC-IV | 11.69 | [8.56, 15.05] | [8.56, 15.62] | [4.98, 19.33] |
| Qwen | MAS | NEJM | 22.22 | [6.67, 40.00] | [6.67, 22.22] | [-6.67, 40.00] |
| Qwen | MAS | NEJM_Ext | 4.17 | [-2.22, 10.83] | [-3.89, 12.78] | [-10.83, 20.00] |
| Qwen | AC | MedQA | 6.23 | [-0.31, 12.77] | [0.62, 9.35] | [-6.54, 16.51] |
| Stratum | Cases | Model | Framework | Native | Direct | Paired 95% CI | Conservative envelope | Native |
|---|---|---|---|---|---|---|---|---|
| Diagnosis | 90 | Qwen2.5-VL-7B | MAS | 13.70 | 45.93 | [23.33, 41.48] | [2.96, 48.89] | — |
| Diagnosis | 90 | Qwen2.5-VL-7B | AC | 14.81 | 54.81 | [30.00, 49.63] | [8.89, 53.33] | — |
| Diagnosis | 90 | Llama3.1-8B | MAS | 12.22 | 49.26 | [27.78, 46.30] | [4.81, 51.48] | — |
| Diagnosis | 90 | Llama3.1-8B | AC | 6.67 | 45.93 | [29.63, 48.52] | [19.26, 58.89] | — |
| Etiology etc. | 13 | Qwen2.5-VL-7B | MAS | 2.56 | 28.21 | [7.69, 46.15] | [2.56, 56.41] | — |
| Etiology etc. | 13 | Qwen2.5-VL-7B | AC | 12.82 | 23.08 | [-5.13, 28.21] | [-12.82, 51.28] | — |
| Model | Framework | Dataset | Paired 95% CI | Holm | ||
|---|---|---|---|---|---|---|
| Qwen3-8B | MAS | MedQA | +21.18 | [13.71, 28.97] | 0.0014 | 91 |
| Qwen3-8B | MAS | MedQA_Ext | +22.74 | [16.98, 28.35] | 0.0014 | 182 |
| Qwen3-8B | MAS | MIMIC-IV | +7.18 | [2.08, 12.27] | 0.0496 | 97 |
| Qwen3-8B | MAS | NEJM | +42.22 | [15.56, 68.89] | 0.0812 | 8 |
| Qwen3-8B | MAS | NEJM_Ext | +33.06 | [24.44, 41.67] | 0.0014 | 86 |
| Qwen3-8B | AC | MedQA | +12.77 | [4.98, 20.56] | 0.0295 | 0 |
Evidence-Grounded Reasoning
Evidence-grounded reasoning studies how AI systems connect conclusions to traceable, relevant evidence and recognize when support is incomplete.
See all 90 papers